Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration.

HOME
>
論文・技術情報
>
Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration.

アブストラクト
ジャーナル名	JAMA internal medicine
Pubmed追加日	2022/8/30
投稿者	Woronow, Daniel; Chamberlain, Christine; Niak, Ali; Avigan, Mark; Houstoun, Monika; Kortepeter, Cindy
組織名	Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology,;Division of Pharmacovigilance, US Food and Drug Administration, Silver Spring,;Maryland.;US Food and Drug Administration, Silver Spring, Maryland.;Center for Drug Evaluation and Research, Office of New Drugs, Division of;Diabetes, Lipid Disorders, and Obesity, US Food and Drug Administration, Silver;Spring, Maryland.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/36036939/